The major players in the 3D medical imaging market are GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Intrasense SA, Materialize NV, Toshiba Group, Samsung Medison Co Ltd, Shimadzu Corporation, and Analogic Corporation.
New York, May 16, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the “3D Medical Imaging Devices Global Market Report 2022” – https://www.reportlinker.com/p06277175/?utm_source=GNW
The global 3D medical imaging devices market is expected to grow from $15.99 billion in 2021 to $15.36 billion in 2022 at a compound annual growth rate (CAGR) of -3.9%. The market is expected to reach $19.32 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%.
The 3D medical imaging market consists of sales of 3D medical imaging equipment and related services. 3D medical imaging is used to create a three-dimensional visual representation of interior parts of the body for medical analysis using computer-aided design (CAD) or magnetic resonance imaging (MRI). ).
The main types of 3D medical imaging are ultrasound, X-rays, CT scans and others. X-rays are used to capture 2D images and create the illusion of 3D X-ray imaging.
The various applications are gynecology and obstetrics, cardiology, neurology, orthopedics and oncology which are used by various end users such as diagnostic centers, hospitals and research centers.
Western Europe was the largest region in the 3D medical imaging market in 2021. Asia-Pacific was the second largest region in the 3D medical imaging market.
Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Rising cases of injuries such as sports-related injuries are contributing to the growth of the 3D medical imaging market. The increase in sports-related injuries is due to the increasing participation of individuals in organized and unorganized sports activities.
In addition, the training of athletes with high strength and load also leads to increasingly serious injuries. Sports injuries are primarily characterized by soft tissue damage.
The use of 3D medical imaging devices such as ultrasound diagnosis, X-ray radiography, MRI imaging provides an accurate and objective basis for diagnosis. 3D medical imaging devices help in the examination of muscle fascia injury, tendon injury, ligament injury, meniscus injury, articular cartilage and bone fracture.
According to the Center for the Disease Control and Prevention, there are an estimated 775,000 emergency room visits due to injuries among children who participate in unorganized and organized sports. Thus, increasing demand for 3D medical imaging devices is driving the growth of the market.
Difficulties faced by the medical device industry due to the COVID-19 outbreak, such as slower orders and supply chain disruptions, are expected to restrain the growth of the 3D medical imaging market in the course of the next few years. According to Medical Products Outsourcing (MPO) magazine published in April 2020, financial strains and supply chain disruptions are the top challenges facing the medical device industry.
Manufacturers are seeing a modest slowdown in orders attributed to tight inventory management due to fears of the virus spreading and slow ordering due to the impact of the virus on businesses. Additionally, managers are also hesitant to oversee new product launches in uncertain times.
This scenario is expected to act as a major limiting factor for the market growth shortly.
Manufacturers of 3D medical imaging devices are increasingly investing in artificial intelligence (AI) to improve diagnosis by providing precise and quantified measurements. AI brings efficiency in medical imaging, especially when it comes to detecting organs or abnormalities. For example, by combining image visualization and AI, cardiologists can measure ejection fraction with high accuracy and over a much shorter period. Ejection fraction is a measure of the percentage of blood leaving the heart each time it contracts. For example, in November 2021, GE Healthcare, a company operating in 3D imaging devices, unveiled 60 innovative technology solutions, including artificial intelligence, to transform healthcare to help patients and clinicians with an effective means of solutions. [i]
In February 2020, Alphatec Holdings, Inc. (ATEC or the Company) acquired EOS Imaging, SA for a purchase price of approximately $88 million. With this acquisition, ATEC will integrate spine imaging and anatomical modeling for improved surgical performance and is expected to significantly increase demand for ATEC hardware and EOS systems. EOS Imaging is a leading French medical device company in orthopedic medical imaging solutions.
Countries covered in 3D Medical Imaging market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom and the United States.
Read the full report: https://www.reportlinker.com/p06277175/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001